Can a common antiseptic outperform standard wart treatment?
NCT ID NCT07830979
First seen Sep 21, 2026 · Last updated Sep 21, 2026
Summary
Researchers compare two topical treatments for plantar warts: hydrogen peroxide 40% applied once weekly and salicylic acid 40% applied daily. The trial enrolls 70 people aged 12 and older with clinically diagnosed plantar warts. The main goal is to see how many participants achieve complete clearance of their warts and how quickly that happens.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Topical hydrogen peroxide 40% solution
- What this could lead to
- If hydrogen peroxide works better than salicylic acid, it could offer a faster, once-weekly treatment for plantar warts that clears the virus completely.
- What could go wrong
- Plantar warts often clear on their own, and both treatments can irritate the skin. The trial is small, so results may not apply to everyone, and hydrogen peroxide may not outperform the standard salicylic acid.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age greater than or equal to 12 years of both sexes * Clinically diagnosed plantar wart or warts * Wart duration at least 2 weeks prior to enrollment * Willing and able to give written informed consent or parental consent for minors * Able to attend follow-up visits and comply with home-application protocol Exclusion Criteria: * Pregnant or lactating women * Immunocompromised patients including HIV infection organ transplant recipients or on immunosuppressive therapy * Diabetic patients with peripheral neuropathy or peripheral arterial disease * Known hypersensitivity to hydrogen peroxide or salicylic acid * Received any topical or systemic wart treatment within preceding 4 weeks * Clinically atypical lesions raising suspicion of malignancy * Active local skin infection or open wound at treatment site * Unable or unwilling to complete follow-up schedule
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Plantar wart are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.